The other important thing to take into account is the vast heterogeneity of cancers. Cancers have been shown to be VERY diverse in their genomic expression profile, meaning you're probably looking at a very small pinhole compared to the entire tumor profile if you sample via biopsy. This diversity helps explains why cancers may initially respond to a specific targeted therapy, but then may reoccur with resistance initial therapy.